News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
EU Backs AstraZeneca PLC and Pozen, Inc.'s Arthritis Pill, Vimovo
October 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Oct 11 (Reuters) - AstraZeneca (AZN.L) and Pozen (POZN.O) said on Monday their pain drug Vimovo had received agreement for marketing approval in 23 European Union countries.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
FDA
FDA Provides Guidance To Prevent Returned Applications, Aid Patient-Focused Drug Development
October 24, 2025
·
2 min read
·
Tristan Manalac
Job Trends
8 Companies Hiring Now in Regulatory
October 23, 2025
·
2 min read
·
Angela Gabriel
Drug pricing
Trump To Target Trading Partners With Drug Pricing Probe: Report
October 22, 2025
·
1 min read
·
Annalee Armstrong
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
October 22, 2025
·
1 min read
·
Heather McKenzie
